Literature DB >> 1246535

Neuropathic and vascular complications occurring in diabetes.

P J Beisswenger.   

Abstract

Vascular and neuropathic complications of diabetes are a significant cause of morbidity and mortality. Symmetric polyneuropathy is the most common diabetic neuropathy. Treatment of the mononeuropathies consists of pain control and physical therapy to maintain muscle tone. Prognosis for recovery is excellent. Renal and retinal microangiopathy produce most of the clinically significant mortality and morbidity in diabetes. Recent advances in chronic hemodialysis and renal transplantation have improved the outlook for diabetics with end-stage nephropathy. The poor prognosis for retention of vision in diabetic malignant retinopathy has led to exploration of various forms of palliative therapy, including pituitary ablation, xenon arc coagulation, and laser treatment. Cardiovascular disease is more prevalent among diabetics than among the general population, according to a recent study, and mortality from this cause is three times higher. Animal studies linking aortic wall metabolism and atherosclerotic changes with hyperglycemia suggest that poor control of diabetes may play a role in the development of vascular lesions.

Entities:  

Mesh:

Year:  1976        PMID: 1246535     DOI: 10.1080/00325481.1976.11716534

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  3 in total

1.  Maladaptive dendritic spine remodeling contributes to diabetic neuropathic pain.

Authors:  Andrew M Tan; Omar A Samad; Tanya Z Fischer; Peng Zhao; Anna-Karin Persson; Stephen G Waxman
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

2.  TrkB signalling pathway mediates the protective effects of exercise in the diabetic rat retina.

Authors:  Rachael S Allen; Adam M Hanif; Marissa A Gogniat; Brian C Prall; Raza Haider; Moe H Aung; Megan C Prunty; Lukas M Mees; Monica M Coulter; Cara T Motz; Jeffrey H Boatright; Machelle T Pardue
Journal:  Eur J Neurosci       Date:  2018-04-03       Impact factor: 3.386

Review 3.  [Hyperglycemia and the complications of maturity-onset diabetes].

Authors:  M D Beaulieu
Journal:  Can Med Assoc J       Date:  1980-04-19       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.